# Anixa Biosciences Inc: Form DEF 14A, filed Feb 6, 2025

- Company: [Anixa Biosciences Inc](/companies/anix.md) (CIK 715446)
- Form: DEF 14A
- Filed: 2025-02-06
- Accepted by EDGAR: Feb 6, 2025, 16:15 ET
- Period: 2024-10-31
- Accession: 0001493152-25-005199
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/715446/000149315225005199/formdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/715446/000149315225005199/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/715446/000149315225005199/formdef14a.htm

Filed Feb 6, 2025.
Source: SEC EDGAR, the filing index for accession 0001493152-25-005199. Last ingested by Listed: Nov 2, 2026, 08:56 ET. No prices; not investment advice.
